Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population

Sponsor
Novo Nordisk A/S (Industry)
Overall Status
Completed
CT.gov ID
NCT00071448
Collaborator
(none)
378
76
24
5
0.2

Study Details

Study Description

Brief Summary

This trial is conducted in the United States of America (USA). The aim of this trial is to to determine whether insulin aspart can be used effectively and safely in paediatric patients.

Condition or Disease Intervention/Treatment Phase
  • Drug: insulin human
  • Drug: insulin lispro
  • Drug: insulin aspart
Phase 3

Study Design

Study Type:
Interventional
Actual Enrollment :
378 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Study Start Date :
Jun 1, 2002
Actual Primary Completion Date :
Jun 1, 2004
Actual Study Completion Date :
Jun 1, 2004

Outcome Measures

Primary Outcome Measures

  1. HbA1c (glycosylated haemoglobin A1c) []

Secondary Outcome Measures

  1. FPG (fasting plasma glucose) []

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Pediatric patients with Type 1 diabetes for at least one year

  • HbA1c less than 12%

  • Willing to administer at least 3 injections per day

  • Willing to perform self monitored blood glucose (SMBG) at least 4 times per day, includes subject and/or parent/guardian, as necessary

Contacts and Locations

Locations

Site City State Country Postal Code
1 Novo Nordisk Investigational Site Birmingham Alabama United States 35294
2 Novo Nordisk Investigational Site Mobile Alabama United States 36617
3 Novo Nordisk Investigational Site Phoenix Arizona United States 85013
4 Novo Nordisk Investigational Site Tucson Arizona United States 85712
5 Novo Nordisk Investigational Site Loma Linda California United States 92354
6 Novo Nordisk Investigational Site Long Beach California United States 90806
7 Novo Nordisk Investigational Site Los Angeles California United States 90027
8 Novo Nordisk Investigational Site Sacramento California United States 95817
9 Novo Nordisk Investigational Site San Diego California United States 92093
10 Novo Nordisk Investigational Site San Diego California United States 92123
11 Novo Nordisk Investigational Site Englewood Colorado United States 80110
12 Novo Nordisk Investigational Site Hartford Connecticut United States 06106
13 Novo Nordisk Investigational Site New Haven Connecticut United States 06520
14 Novo Nordisk Investigational Site Gainesville Florida United States 32605
15 Novo Nordisk Investigational Site Gainesville Florida United States 32608
16 Novo Nordisk Investigational Site Miami Florida United States 33136
17 Novo Nordisk Investigational Site Orlando Florida United States 32806-1101
18 Novo Nordisk Investigational Site Pensacola Florida United States 32504
19 Novo Nordisk Investigational Site Tallahassee Florida United States 32308
20 Novo Nordisk Investigational Site Tampa Florida United States 33612
21 Novo Nordisk Investigational Site Atlanta Georgia United States 30342
22 Novo Nordisk Investigational Site Idaho Falls Idaho United States 83404-7596
23 Novo Nordisk Investigational Site Indianapolis Indiana United States 46202-2879
24 Novo Nordisk Investigational Site Indianapolis Indiana United States 46250
25 Novo Nordisk Investigational Site Iowa City Iowa United States 52242
26 Novo Nordisk Investigational Site Baton Rouge Louisiana United States 70808
27 Novo Nordisk Investigational Site New Orleans Louisiana United States 70127-5430
28 Novo Nordisk Investigational Site Baltimore Maryland United States 21201
29 Novo Nordisk Investigational Site Baltimore Maryland United States 21229
30 Novo Nordisk Investigational Site Boston Massachusetts United States 02115
31 Novo Nordisk Investigational Site Boston Massachusetts United States 02215
32 Novo Nordisk Investigational Site Worcester Massachusetts United States 01655
33 Novo Nordisk Investigational Site Ann Arbor Michigan United States 48109
34 Novo Nordisk Investigational Site Minneapolis Minnesota United States 55416
35 Novo Nordisk Investigational Site Rochester Minnesota United States 55905
36 Novo Nordisk Investigational Site Kansas City Missouri United States 64108
37 Novo Nordisk Investigational Site Omaha Nebraska United States 68114
38 Novo Nordisk Investigational Site Omaha Nebraska United States 68198-3020
39 Novo Nordisk Investigational Site Hackensack New Jersey United States 07601
40 Novo Nordisk Investigational Site Morristown New Jersey United States 07962
41 Novo Nordisk Investigational Site Paterson New Jersey United States 07503
42 Novo Nordisk Investigational Site Albuquerque New Mexico United States 87102
43 Novo Nordisk Investigational Site Albany New York United States 12208
44 Novo Nordisk Investigational Site Brooklyn New York United States 11219
45 Novo Nordisk Investigational Site Buffalo New York United States 53226
46 Novo Nordisk Investigational Site Mineola New York United States 11501
47 Novo Nordisk Investigational Site New York New York United States 10022
48 Novo Nordisk Investigational Site New York New York United States 10029
49 Novo Nordisk Investigational Site Rochester New York United States 14642
50 Novo Nordisk Investigational Site Chapel Hill North Carolina United States 27599-7220
51 Novo Nordisk Investigational Site Akron Ohio United States 44308-1062
52 Novo Nordisk Investigational Site Cleveland Ohio United States 44195
53 Novo Nordisk Investigational Site Columbus Ohio United States 43231
54 Novo Nordisk Investigational Site Dayton Ohio United States 45404
55 Novo Nordisk Investigational Site Portland Oregon United States 97227
56 Novo Nordisk Investigational Site Danville Pennsylvania United States 17822
57 Novo Nordisk Investigational Site Erie Pennsylvania United States 16507
58 Novo Nordisk Investigational Site Hershey Pennsylvania United States 17033
59 Novo Nordisk Investigational Site Philadelphia Pennsylvania United States 19104
60 Novo Nordisk Investigational Site Pittsburgh Pennsylvania United States 15213-3417
61 Novo Nordisk Investigational Site Charleston South Carolina United States 29425
62 Novo Nordisk Investigational Site Columbia South Carolina United States 29203
63 Novo Nordisk Investigational Site Greer South Carolina United States 29651
64 Novo Nordisk Investigational Site Memphis Tennessee United States 38103
65 Novo Nordisk Investigational Site Memphis Tennessee United States 38119
66 Novo Nordisk Investigational Site Corpus Christi Texas United States 78411
67 Novo Nordisk Investigational Site Dallas Texas United States 75235
68 Novo Nordisk Investigational Site Lackland Texas United States 78236
69 Novo Nordisk Investigational Site San Antonio Texas United States 78229
70 Novo Nordisk Investigational Site San Antonio Texas United States 78284
71 Novo Nordisk Investigational Site Temple Texas United States 76508
72 Novo Nordisk Investigational Site Salt Lake City Utah United States 84132
73 Novo Nordisk Investigational Site Norfolk Virginia United States 23510
74 Novo Nordisk Investigational Site Spokane Washington United States 99201
75 Novo Nordisk Investigational Site Morgantown West Virginia United States 26506
76 Novo Nordisk Investigational Site Madison Wisconsin United States 53792

Sponsors and Collaborators

  • Novo Nordisk A/S

Investigators

  • Study Director: Global Clinical Registry (GCR, 1452), Novo Nordisk A/S

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Novo Nordisk A/S
ClinicalTrials.gov Identifier:
NCT00071448
Other Study ID Numbers:
  • ANA-2126
First Posted:
Oct 24, 2003
Last Update Posted:
Dec 22, 2016
Last Verified:
Dec 1, 2016

Study Results

No Results Posted as of Dec 22, 2016